HomeInsightsMarket Capitalization

Market Capitalization of Transgene Biotek Ltd

Market Capitalization of Transgene Biotek Ltd

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

78.2 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

MARKETCAP

₹ 49.33 crore

Last updated on: Nov 07, 2024

Key Highlights

  • The Market Cap of Transgene Biotek Ltd is ₹ 49.33 crore as of 07 Nov 24.
  • The Market Cap of Transgene Biotek Ltd changed from ₹ 30.31 crore on March 2019 to ₹ 18.87 crore on March 2023 . This represents a CAGR of -9.04% over 5 years. .
  • The Latest Trading Price of Transgene Biotek Ltd is ₹ 6.51 as of 07 Nov 15:30.

Historical Market Cap of Transgene Biotek Ltd

No data available

* All values are in crore

Company Fundamentals for Transgene Biotek Ltd

No data available

Image

Transgene Biotek Ltd

NSE: TRANSGENEBIOTEK

PRICE

₹ 6.51

-0.34 (-4.96%)

stock direction

Last updated on: Nov 07 03:30 PM

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Transgene Biotek Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20246.51
06 Nov 20246.85
05 Nov 20246.77
04 Nov 20246.79
01 Nov 20247.07
31 Oct 20246.93
30 Oct 20246.88
29 Oct 20246.82
28 Oct 20246.59
25 Oct 20246.78

SWOT Analysis Of Transgene Biotek Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Transgene Biotek Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Transgene Biotek Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Transgene Biotek Ltd

No data available

No data available

Historical P/E Ratio of Transgene Biotek Ltd

No data available

* All values are in %

Historical Revenue of Transgene Biotek Ltd

No data available

* All values are in crore

Historical EBITDA of Transgene Biotek Ltd

No data available

* All values are in crore

Historical Net Profit of Transgene Biotek Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

About Transgene Biotek Ltd

  • Founded in March, 1990 by Dr. Koteswara Rao, Transgene Biotek Ltd was one of the first Biotechnology companies in India.
  • Although Transgene began life manufacturing and selling diagnostic kits, it soon moved on to true biotech research, including the research and development of vaccines, oncology , New drug delivery technologies etc.
  • The first major success came when it sold genetically engineered recombinant Hepatitis B vaccine technology along with novel and patented process in 1999 to the Serum Institute, Pune. Presently, the Company is engaged in the business of research and development and manufacture of various medical reagents, both chemical and immuno-diagnostic reagents for qualitative and quantitative estimation of bio-chemical parameters and diagnosis of diseases respectively.

Transgene Biotek Ltd News Hub

News

Transgene Biotek to announce Quarterly Result

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 12 Novemb...

Read more

05 Nov 202412:01

News

Transgene Biotek to hold board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 10 August...

Read more

20 Jul 202412:06

News

Transgene Biotek schedules board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 30 May 20...

Read more

13 May 202411:11

News

Transgene Biotek to conduct board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 Februa...

Read more

30 Jan 202414:56

News

Transgene Biotek schedules AGM

Transgene Biotek announced that the 33th Annual General Meeting (AGM) of the company will ...

Read more

16 Nov 202317:30

News

Transgene Biotek schedules board meeting

Transgene Biotek will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

07 Nov 202316:38

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Transgene Biotek Ltd Market Cap

What is the market cap of Transgene Biotek Ltd?

As of November 8, 2024, Transgene Biotek Ltd has a market capitalization of ₹49.33, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Transgene Biotek Ltd's market capitalization?

Transgene Biotek Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Transgene Biotek Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Transgene Biotek Ltd's market capitalization change?

Transgene Biotek Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*